Suppr超能文献

哌拉西林/他唑巴坦引起的全身性固定性药疹及文献复习

Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.

作者信息

Kornmehl Heather, Gorouhi Farzam, Konia Thomas, Fung Maxwell A, Tartar Danielle M

机构信息

University of California Davis, Sacramento, California.

出版信息

Dermatol Online J. 2018 Apr 15;24(4):13030/qt8cr714g5.

Abstract

Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces. The reaction occurs on the same mucosal or cutaneous site with subsequent exposures to the offending drug. Although FDE usually manifests as a single lesion, in rare instances, more than one lesion may arise and this is referred to as a generalized eruption. Herein, we present a 31year-old man with history of cystic fibrosis who developed a generalized fixed drug eruption to piperacillin/tazobactam (Zosyn, Pfizer). We discuss our patient's course and review causes and outcomes of generalized fixed drug eruptions in the literature.

摘要

固定性药疹(FDE)是一种药物不良反应,其特征为在皮肤或黏膜表面出现边界清晰的圆形暗红色斑疹和斑块。再次接触致病药物时,反应会出现在相同的黏膜或皮肤部位。虽然FDE通常表现为单个皮损,但在罕见情况下,可能会出现不止一个皮损,这被称为泛发性皮疹。在此,我们报告一名31岁患有囊性纤维化病史的男性,他因哌拉西林/他唑巴坦(Zosyn,辉瑞公司)出现了泛发性固定性药疹。我们讨论了该患者的病程,并回顾了文献中泛发性固定性药疹的病因和转归。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验